Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Alírica Isabel SuárezUnidad de Investigación en Productos Naturales, Facultad de Farmacia, Universidad Central de Venezuela, Caracas 1040, Venezuela.
Katiuska ChávezUnidad de Investigación en Productos Naturales, Facultad de Farmacia, Universidad Central de Venezuela, Caracas 1040, Venezuela.
Jenny Valentina GarmendiaInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Claudia Valentina De SanctisInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.ORCID 0000-0002-7864-7379
Soňa GurskáInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Petr DžubákInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.ORCID 0000-0002-3098-5969
Marian HajduchInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.ORCID 0000-0002-4834-908X
Juan Bautista De SanctisInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.ORCID 0000-0002-5480-4608
Funding
Czech biobank network LM2023033Czech National Node to the European Infrastructure for Translational Medicine LM2023052CZ-OPENSCREEN LM2023052Ministry of Education, Youth and Sports of the Czech Republic. SAVAGE Project CZ.02.01.01/00/22_008/0004644National Institute for Cancer Research Program EXCELES . LX22NPO5102Technology Agency of the Czech Republic TN02000109Venezuelan Ministry of Science and Technology and FONACIT Project 20230PGP99
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
New Derivatives of Caracasine Acid with Anti-Leukemic Activity and Limited Effectiveness in Spheroid Cultures. · full record | Socratic